近期论文
查看导师最新文章
（温馨提示：请注意重名现象，建议点开原文通过作者单位确认）
1.Wang W, Xu DZ, Li YF, Guan YX, Sun XW, Chen YB, Kesari R, Huang CY, Li W, Zhan YQ, Zhou ZW. Tumor-Ratio-Metastasis Staging System as an Alternative to the 7th edition UICC TNM System in Gastric Cancer after D2 Resection - Results of a Single Institution Study of 1343 Chinese Patients. Ann Oncol. 2011, Sep;22 (9):2049-56. IF=13.93 2.Fang C, Wang W, Feng X, Sun J, Zhang Y, Zeng Y, Wang J, Chen H, Cai M, Lin J, Chen M, Chen Y, Li Y, Li S, Chen J, Zhou Z. Nomogram individually predicts the overall survival of patients with gastroenteropancreatic neuroendocrine neoplasms. Br J Cancer. 2017 Nov 7;117(10):1544-1550. Epub 2017 Sep 26. [Co-first author] IF=5.92 3.Wang P, Sun Z, Wang W, Deng J, Wang Z, Liang H, Zhou Z, Xu H. Conditional survival of patients with gastric cancer who undergo curative resection: A multi-institutional analysis in China. Cancer. 2018 Mar 1;124(5):916-924. [Co-first author] IF=6.54 4.Liang Y, Wang W, Fang C, Raj SS, Hu WM, Li QW, Zhou ZW. Clinical significance and diagnostic value of serum CEA, CA19-9 and CA72-4 in patients with gastric cancer. Oncotarget. 2016 Aug 2;7(31):49565-49573. [Co-first author] IF=5.17 5.Qi X, Liu Y, Wang W, Cai D, Li W, Hui J, Liu C, Zhao Y, Li G. Management of advanced gastric cancer: An overview of major findings from meta-analysis. Oncotarget. 2016 Nov 22;7(47):78180-78205. [Co-first author] IF=5.17 6.Fang C, Wang W, Zhang Y, Feng X, Sun J, Zeng Y, Chen Y, Li Y, Chen M, Zhou Z, Chen J. Clinicopathologic characteristics and prognosis of gastroenteropancreatic neuroendocrine neoplasms: a multicenter study in South China. Chin J Cancer. 2017 Jun 21;36(1):51. [Co-first author] IF=4.12 7.Wang W, Li YF, Sun XW, Chen YB, Li W, Xu DZ, Guan XX, Huang CY, Zhan YQ, Zhou ZW. Prognosis of 980 patients with gastric cancer after surgical resection. Chin J Cancer. 2010; 29 (11),923-930 IF=4.12 8.Wang W, Li YF, Sun XW, Chen G, Zhan YQ, Huang CY, Wan DS, Pan ZZ, Zhou ZW. Correlation analysis between loss of heterozygosity at chromosome 18q and prognosis in the stage II colon cancer patients. Chin J Cancer, 2010? 29 (8): 761-767 IF=4.12 9.Wang W, Seeruttun SR, Fang C, Chen J, Li Y, Liu Z, Zhan Y, Li W, Chen Y, Sun X, Li Y, Xu D, Guan Y, Zhou Z. Prognostic Significance of Carcinoembryonic Antigen Staining in Cancer Tissues of Gastric Cancer Patients. Ann Surg Oncol. 2015 Nov 30. [Epub ahead of print] IF=4.04 10.Wang W, Sun XW, Li CF, Lv L, Li YF, Chen YB, Xu DZ, Kesari R, Huang CY, Li W, Zhan YQ, Zhou ZW. Comparison of the 6th and 7th editions of the UICC TNM staging system for gastric cancer - results of a Chinese single institution study of 1503 patients. Ann Surg Oncol. 2011, 18: 1060-1067 IF=4.04 11.Lu J, Wang W, Zheng CH, Fang C, Li P, Xie JW, Wang JB, Lin JX, Chen QY, Cao LL, Lin M, Huang CM, Zhou ZW. Influence of Total Lymph Node Count on Staging and Survival After Gastrectomy for Gastric Cancer: An Analysis From a Two-Institution Database in China. Ann Surg Oncol. 2017 Feb;24(2):486-493. doi: 10.1245/s10434-016-5494-7. Epub 2016 Sep 12. [Co-first author] IF=4.04 12.Li B, Li Y, Wang W, Qiu H, Seeruttun SR, Fang C, Chen Y, Liang Y, Li W, Chen Y, Sun X, Guan Y, Zhan Y, Zhou Z. Incorporation of N0 stage with insufficient numbers of lymph nodes into N1 stage in the seventh edition of the TNM classification improves prediction of prognosis in gastric cancer----results of a single-institution study of 1258 Chinese patients. Ann Surg Oncol. 2015 May 19. [Epub ahead of print] [Co-first author] IF=4.04 13.Pan K, Li YQ, Wang W, Xu L, Zhang YJ, Zheng HX, Zhao JJ, Qiu HJ, Weng DS, Li JJ, Wang QJ, Huang LX, He J, Chen SP, Ke ML, Wu PH, Chen MS, Li SP, Xia JC, Zeng YX. The Efficacy of Cytokine-Induced Killer Cell Infusion as an Adjuvant Therapy for Postoperative Hepatocellular Carcinoma Patients. Ann Surg Oncol. 2013 Dec;20(13):4305-11. [Co-first author] IF=4.04 14.Wang W, Zheng C, Fang C, Li P, Xie J, Lin J, Zhan Y, Li W, Chen Y, Sun X, Xu D, Li Y, Huang C, Zhou Z. Time trends of clinicopathologic features and surgical treatment for gastric cancer: Results from 2 high-volumeinstitutions in southern China. Surgery. 2015 Dec;158(6):1590-7. doi: 10.1016/j.surg.2015.04.038. Epub 2015 Jul 23. IF=3.90 15.Wang W, Wang GQ, Sun XW, Chen G, Li YF, Zhang LY, Qiu HB, Huang CY, Zhan YQ, Zhou ZW. Prognostic values of chromosome 18q microsatellite alterations in stage II colonic carcinoma. World J Gastroenterol, 2010; 16(47), 6026-6034 IF=3.37 16.Wang W, Liu Z, Sun P, Fang C, Fang H, Wang Y, Ji J, Chen J. RGD Peptides-Conjugated Pluronic Triblock Copolymers Encapsulated with AP-2α Expression Plasmid for Targeting Gastric Cancer Therapy in Vitro and in Vivo. Int J Mol Sci. 2015 Jul 17;16(7):16263-74. doi: 10.3390/ijms160716263. IF=3.23 17.Wang W, Seeruttun SR, Fang C, Zhou Z. Comprehensive treatment of a functional pancreatic neuroendocrine tumor with multifocal liver metastases. Chin J Cancer Res. 2014 Aug;26(4):501-6. IF=3.00
京公网安备 11010802027423号